Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.

Samsung Biologics Co.,Ltd.

207940

Clasificación en acciones #496
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Precio por acción
$1,028.49
Capitalización bursátil
$47.88B
Cambio (1 día)
-3.67%
Cambio (1 año)
-18.37%
País
KR
Comercio Samsung Biologics Co.,Ltd. (207940)

Categoría

Healthcare
Ratio P/S de Samsung Biologics Co.,Ltd. (207940)
Ratio P/S al October 2026 TTM: 14.48
Según los informes financieros más recientes y el precio de las acciones de Samsung Biologics Co.,Ltd., el ratio P/S actual (TTM) es 14.48. Al final de 2024, el ratio P/S era 19.31.
Historial del ratio P/S de Samsung Biologics Co.,Ltd. desde 2014 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
2026 (TTM) 14.48 -15.84%
2025 17.20 -10.95%
2024 19.31 27.07%
2023 15.20 -20.91%
2022 19.22 -50.09%
2021 38.51 -18.79%
2020 47.42 14.90%
2019 41.27 -11.58%
2018 46.67 -16.73%
2017 56.06 83.95%
2016 30.47 -74.24%
2015 118.31 15.20%
2014 102.70 0.00%
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
10.72 -25.93%
US
41.70 188.07%
US
4.19 -71.05%
AU
5.80 -59.96%
BE
10.44 -27.86%
NL